ESG Sustainability Report

Overview

The report describes PharmaEssentia's 2024 commercial growth, including annual revenue of NT$9.73 billion, alongside expanded sustainability governance and board diversity. It reports total energy consumption of 46,573.36 GJ and continued environmental management through ISO systems and climate-related disclosures. The sustainability report was independently assured by AFNOR Asia Ltd. under AA1000 AS v3, with the assurer concluding that the information provides a fair and balanced representation.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis
Matrix

Assurance

Provider
Level
Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview